Immunological responses to pneumococcal vaccine in frail older people
- 4 March 2009
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 27 (10), 1628-1636
- https://doi.org/10.1016/j.vaccine.2008.11.098
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineVaccine, 2007
- Age-related changes in immunity: implications for vaccination in the elderlyExpert Reviews in Molecular Medicine, 2007
- Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 StudyClinical Infectious Diseases, 2006
- Streptococcus pneumoniae: Epidemiology, Risk Factors, and Clinical FeaturesSeminars in Respiratory and Critical Care Medicine, 2005
- Effectiveness of a 23-valent Polysaccharide Vaccine in Preventing Pneumonia and Non-invasive Pneumococcal Infection in Elderly People: A Large-scale Retrospective Cohort StudyJournal of International Medical Research, 2005
- Effectiveness of Pneumococcal Polysaccharide Vaccine in Older AdultsThe New England Journal of Medicine, 2003
- Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and managementEuropean Journal of Pediatrics, 2002
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- The burden of pneumococcal disease among adults in developed and developing countries: what is and is not knownVaccine, 1999
- Vaccination Against Streptococcus pneumoniae in Childhood: Lack of Demonstrable Benefit in Young Australian ChildrenThe Journal of Infectious Diseases, 1984